Skip to Content
 
International Parkinson and Movement Disorder Society
Main Content

Anti-inflammatory drugs use impacts the risk of developing PD in LRRK2 mutation carriers

November 09, 2020
Episode:35
Dr. Marta San Luciano shares the main findings of the recently published article on the impact of non-steroidal anti-inflammatory drugs use on the risk of developing PD in a large LRRK2 mutation carriers cohort. Read the article
Read More
Special thank you to:Dr. Marta San Luciano
Host(s):
Michele Matarazzo, MD 

Neurologist and clinical researcher HM CINAC

Madrid, Spain
Previous

All Episodes

Next